Relationship between serum anti-Leishmania antibody levels and acute phase proteins in dogs with canine leishmaniosis

• Published in: Veterinary parasitology Vol. 260; pp. 63 - 68
• Main Authors: Cantos-Barreda, Ana, Escribano, Damián, Cerón, José J., Bernal, Luis J., Furlanello, Tommaso, Tecles, Fernando, Pardo-Marín, Luis, Martínez-Subiela, Silvia
• Format: Journal Article
• Language: English
• Published: Netherlands Elsevier B.V 30.08.2018
• Subjects: Acute phase proteins; Acute-Phase Proteins - analysis; Animals; Anti-Leishmania antibodies; Antibodies, Protozoan - blood; Antibodies, Protozoan - immunology; Biomarkers - blood; C-Reactive Protein - analysis; Canine leishmaniosis; Correlation of Data; Correlation study; Dog Diseases - blood; Dog Diseases - epidemiology; Dog Diseases - immunology; Dog Diseases - parasitology; Dogs; ELISA; Enzyme-Linked Immunosorbent Assay; Ferritins - blood; Leishmania infantum - immunology; Leishmaniasis - blood; Leishmaniasis - immunology; Leishmaniasis - parasitology; Leishmaniasis - veterinary; Leishmaniasis, Visceral - blood; Leishmaniasis, Visceral - immunology; Leishmaniasis, Visceral - parasitology; Leishmaniasis, Visceral - veterinary; Sensitivity and Specificity; Spain - epidemiology; TR-IFMA; Spain; Correlation study; TR-IFMA; Canine leishmaniosis; Anti-Leishmania antibodies; Acute phase proteins; ELISA
• ISSN: 0304-4017; 1873-2550
• DOI: 10.1016/j.vetpar.2018.08.010

•There are no changes in inflammatory biomarkers between Leishmania-seropositive and seronegative dogs.•Dogs with higher serology showed more abnormalities in biochemical analytes.•Ferritin and CRP were more correlated with serology by TR-IFMA during treatment monitoring. This study examined the relationship between two serologic assays which quantify anti-Leishmania antibodies (a commercial enzyme-linked immunosorbent assay (ELISA) and a time-resolved immunofluorometric assay (TR-IFMA)) and selected acute phase proteins (APPs) and analytes related to protein concentration. Data were obtained from 205 canine serum samples from different veterinary clinics located in an area in which canine leishmaniosis (CanL) is endemic. The samples were submitted to the Interdisciplinary Laboratory of Clinical Analysis (Interlab-UMU), University of Murcia, Spain, for analysis. The biochemical analytes evaluated were serum ferritin, C-reactive protein (CRP), haptoglobin, paraoxonase-1 (PON-1) and albumin as APPs and total proteins and globulins as indicative analytes of protein concentration. Samples were submitted for the initial diagnosis of CanL, or to monitor the response to treatment in patients with CanL. The evaluation of the biochemical analytes did not show differences between Leishmania-seronegative and Leishmania-seropositive dogs. However, dogs with high antibody titers showed more pronounced clinicopathological abnormalities. Both serological assays had correlations of different significance with the biochemical analytes, showing higher significant correlations with total proteins and globulins than with the rest of the analytes. When the samples submitted for diagnosis and treatment monitoring were analyzed separately, serological assays showed lower correlation in samples for treatment monitoring (r = 0.531, p <  0.0001) than in samples for diagnosis (r = 0.769, p <  0.0001). In addition, higher correlations were found between TR-IFMA and analytes such as serum ferritin and CRP in the treatment monitoring group than with the ELISA. These results may help to clarify the relationship between anti-Leishmania antibody levels and selected biochemical analytes related to inflammation and protein concentration in CanL.